Atlas Trials

Bioequivalence Study of Trifluridine and Tipiracil Hydrochloride Tablets on Fasting and Fed in Humans

Clinical trial NCT07492173 · COMPLETED

Trial details

NCT number
NCT07492173
Sponsor
Shandong New Time Pharmaceutical Co., LTD
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Solid Tumor Cancer
Start date
2022-11-21
Primary completion
2023-06-25
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.